FI941169A - Transvascular and intracellular administration of lipidized proteins - Google Patents
Transvascular and intracellular administration of lipidized proteins Download PDFInfo
- Publication number
- FI941169A FI941169A FI941169A FI941169A FI941169A FI 941169 A FI941169 A FI 941169A FI 941169 A FI941169 A FI 941169A FI 941169 A FI941169 A FI 941169A FI 941169 A FI941169 A FI 941169A
- Authority
- FI
- Finland
- Prior art keywords
- transvascular
- intracellular administration
- lipidized proteins
- lipidized
- proteins
- Prior art date
Links
- 230000003834 intracellular effect Effects 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91245392A | 1992-07-13 | 1992-07-13 | |
| PCT/US1993/006599 WO1994001131A1 (en) | 1992-07-13 | 1993-07-13 | Transvascular and intracellular delivery of lipidized proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI941169A0 FI941169A0 (en) | 1994-03-11 |
| FI941169A true FI941169A (en) | 1994-05-04 |
Family
ID=25431949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI941169A FI941169A (en) | 1992-07-13 | 1994-03-11 | Transvascular and intracellular administration of lipidized proteins |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0607408A4 (en) |
| JP (1) | JPH07502753A (en) |
| KR (2) | KR20030097604A (en) |
| AU (1) | AU4772793A (en) |
| CA (1) | CA2118586A1 (en) |
| FI (1) | FI941169A (en) |
| NZ (1) | NZ255043A (en) |
| OA (1) | OA09893A (en) |
| RU (1) | RU2157239C2 (en) |
| WO (1) | WO1994001131A1 (en) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5543390A (en) | 1990-11-01 | 1996-08-06 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University | Covalent microparticle-drug conjugates for biological targeting |
| US5827819A (en) * | 1990-11-01 | 1998-10-27 | Oregon Health Sciences University | Covalent polar lipid conjugates with neurologically active compounds for targeting |
| NZ313839A (en) * | 1995-07-21 | 1998-12-23 | Genta Inc | Amide-based cationic lipids |
| US7045543B2 (en) | 2001-11-05 | 2006-05-16 | Enzrel Inc. | Covalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites |
| CA2472927A1 (en) | 2002-01-10 | 2003-07-17 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | A novel splice variant of myd88 and uses thereof |
| WO2003080115A1 (en) * | 2002-03-22 | 2003-10-02 | Bipha Corporation | Immunoglobulin/hydrophilic peptide complexes |
| WO2006085149A2 (en) | 2004-12-22 | 2006-08-17 | Neurochem (International) Limited | Methods and compositions for treating amyloid-related diseases |
| WO2007082899A1 (en) | 2006-01-17 | 2007-07-26 | Vib Vzw | Inhibitors of prolyl-hydroxylase 1 for the treatment of skeletal muscle degeneration |
| CN101405401B (en) * | 2006-03-16 | 2013-03-27 | 斯克利普斯研究院 | Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine |
| PL3851447T3 (en) | 2006-10-12 | 2024-03-04 | Bellus Health Inc. | Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
| EP2092080A1 (en) | 2006-11-07 | 2009-08-26 | Vib Vzw | Diagnosis and treatment of t-cell acute lymphoblastic leukemia |
| EP2096121A1 (en) * | 2008-02-29 | 2009-09-02 | Institut Pasteur Of Shanghai | Antiviral peptides comprising lipid attachment signals and methods of use |
| EP2342356A4 (en) | 2008-09-29 | 2012-11-21 | Univ Ben Gurion | Amyloid beta-peptides and methods of use thereof |
| WO2012001178A1 (en) | 2010-07-02 | 2012-01-05 | Vib Vzw | The role of fragile x mental retardation gene and protein in cancer metastasis |
| GB201012845D0 (en) | 2010-07-30 | 2010-09-15 | Vib Vzw | Inhibition of dicer function for treatment of cancer |
| UY33679A (en) * | 2010-10-22 | 2012-03-30 | Esbatech | STABLE AND SOLUBLE ANTIBODIES |
| GB2511928B (en) | 2011-09-14 | 2015-04-08 | Abeterno Ltd | Intracellular cell selection |
| WO2013121042A1 (en) | 2012-02-16 | 2013-08-22 | Vib Vzw | PP2A SUBUNITS IN DNA REPAIR, THE PP2A B55α SUBUNIT AS NOVEL PHD2 INTERACTING PROTEIN, AND IMPLICATIONS FOR CANCER |
| GB201306589D0 (en) | 2013-04-11 | 2013-05-29 | Abeterno Ltd | Live cell imaging |
| CA2922698C (en) | 2013-08-29 | 2023-01-03 | City Of Hope | Cell penetrating conjugates comprising non-cell penetrating antibodies covalently attached to one or more phosphorothioate nucleic acids |
| KR101470793B1 (en) * | 2014-06-30 | 2014-12-08 | 순천향대학교 산학협력단 | Peptide as permeation enhancer and composition including the same |
| CN110997693A (en) | 2017-06-07 | 2020-04-10 | 阿德克斯公司 | Tau aggregation inhibitors |
| WO2019036725A2 (en) | 2017-08-18 | 2019-02-21 | Adrx, Inc. | Tau aggregation peptide inhibitors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4429008B1 (en) * | 1981-12-10 | 1995-05-16 | Univ California | Thiol reactive liposomes |
| EP0306912A3 (en) * | 1987-09-08 | 1989-07-05 | Albany Medical College | Immunogenic composites capable of selectively inducing antibody production and pharmaceutical compositions employing the same. |
| ATE104857T1 (en) * | 1989-03-07 | 1994-05-15 | Genentech Inc | COVALENT CONJUGATES OF LIPIDS AND OLIGONUCLEOTIDES. |
| WO1991000289A2 (en) * | 1989-06-23 | 1991-01-10 | The Liposome Company, Inc. | Targeted liposomes and methods for liposome-protein coupling |
| US5264618A (en) * | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
| DE69124590T2 (en) * | 1990-07-24 | 1997-06-12 | Seikagaku Kogyo K K Seikagaku | GLYCOSAMINOGLYCAN MIXED WITH PHOSPHOLIPID OR LIPID, ITS PRODUCTION AND CANCER CELL METASTASE INHIBITOR |
-
1993
- 1993-07-13 RU RU94024566/14A patent/RU2157239C2/en not_active IP Right Cessation
- 1993-07-13 WO PCT/US1993/006599 patent/WO1994001131A1/en not_active Application Discontinuation
- 1993-07-13 KR KR1020027011377A patent/KR20030097604A/en not_active Application Discontinuation
- 1993-07-13 JP JP6503580A patent/JPH07502753A/en active Pending
- 1993-07-13 KR KR1019940700829A patent/KR100372119B1/en not_active IP Right Cessation
- 1993-07-13 EP EP93918190A patent/EP0607408A4/en not_active Withdrawn
- 1993-07-13 AU AU47727/93A patent/AU4772793A/en not_active Abandoned
- 1993-07-13 CA CA002118586A patent/CA2118586A1/en not_active Abandoned
- 1993-07-13 NZ NZ255043A patent/NZ255043A/en unknown
-
1994
- 1994-03-11 OA OA60481A patent/OA09893A/en unknown
- 1994-03-11 FI FI941169A patent/FI941169A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| OA09893A (en) | 1994-09-15 |
| RU94024566A (en) | 1996-09-27 |
| WO1994001131A1 (en) | 1994-01-20 |
| CA2118586A1 (en) | 1994-01-20 |
| RU2157239C2 (en) | 2000-10-10 |
| FI941169A0 (en) | 1994-03-11 |
| AU4772793A (en) | 1994-01-31 |
| EP0607408A1 (en) | 1994-07-27 |
| KR20030097604A (en) | 2003-12-31 |
| KR100372119B1 (en) | 2003-06-28 |
| JPH07502753A (en) | 1995-03-23 |
| EP0607408A4 (en) | 1997-12-10 |
| NZ255043A (en) | 1997-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI941169A0 (en) | Transvascular and intracellular administration of lipidized proteins | |
| FI932722A0 (en) | Glucagonic peptide and insulinotropin derivatives | |
| FI972657A (en) | Aerosol formulations of peptides and proteins | |
| FI932960A0 (en) | Control of fructors mogning and vaexters foeraoldring | |
| FI935485A0 (en) | PEG-hydrazone and PEG-oxybinding compounds and protein derivatives | |
| ATE276762T1 (en) | STABLE LYOPHILIZED PHARMACEUTICAL PREPARATIONS OF MONO- OR POLYCONAL ANTIBODIES | |
| IT1224421B (en) | MODIFIED GALATTOMANNANS AND REALIVE PREPARATION PROCEDURE | |
| DE69322062T2 (en) | EMULSION POLYMERS AND THEIR USE IN HAIR-TENSIONING PREPARATIONS | |
| FI960353A (en) | Agonists and antagonists of human interleukin-10 | |
| NO964758D0 (en) | Use of von Willebrand factor and pharmaceutical preparations | |
| DK56891A (en) | APPLICATION OF PESTICIDE PREPARATIONS | |
| FI954491A (en) | Heterocycles containing imidine derivatives, their preparation and use | |
| NO971668L (en) | Lyophilisate of lipid complex of water-insoluble camptothecins | |
| DE68923860T2 (en) | Derivatives of alcohols and ethers. | |
| ITMI921413A0 (en) | STABLE PHARMACEUTICAL PREPARATIONS OF NICORANDIL | |
| FI932114A0 (en) | Maolspecifika erythrocytes and thromboerytrocytes | |
| NO973826D0 (en) | New use of mother-of-pearl preparations | |
| FI935789A0 (en) | Explanation and use of explosive substances | |
| DE69616889D1 (en) | Compression of moving pictures | |
| SE458083B (en) | ELRADIATOR AND APPLICATION OF THE SAME | |
| BR9106742A (en) | PREPARATION OF ANYTHING NIOBIO AND TANTALO PENTAFLUORIDES | |
| FI920758A (en) | COMPOSITION AND DESIGN OF SAOSOM BIOCID | |
| DK82592D0 (en) | PREPARATION OF PROTEINS | |
| NO940877L (en) | Transvascular and intracellular delivery of lipidized proteins | |
| FI971086A0 (en) | Kinase-binding protein and its use |